4.7 Editorial Material

Cancer risk after bariatric surgery - is colorectal cancer a special case?

Journal

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY
Volume 15, Issue 11, Pages 653-654

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41575-018-0070-1

Keywords

-

Funding

  1. MRC [MR/L01629X/1] Funding Source: UKRI
  2. Medical Research Council [MR/L01629X/1] Funding Source: Medline

Ask authors/readers for more resources

Bariatric surgery-induced weight loss is associated with reduced overall cancer incidence; however, some data suggest that risk of colorectal cancer (CRC) actually increases. Here, we suggest a need to fully characterise CRC (and colorectal adenoma) risk after bariatric surgery given that preventive measures (early diagnosis and polypectomy) can mitigate risk.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer

Mark Lawler, Deborah Alsina, Richard A. Adams, Annie S. Anderson, Gina Brown, Nicola S. Fearnhead, Stephen W. Fenwick, Stephen P. Halloran, Daniel Hochhauser, Mark A. Hull, Viktor H. Koelzer, Angus G. K. McNair, Kevin J. Monahan, Inke Nathke, Christine Norton, Marco R. Novelli, Robert J. C. Steele, Anne L. Thomas, Lisa M. Wilde, Richard H. Wilson, Ian Tomlinson

Article Gastroenterology & Hepatology

Increasing Prescription of Opiates and Mortality in Patients With Inflammatory Bowel Diseases in England

Nicholas E. Burr, Chris Smith, Robert West, Mark A. Hull, Venkataraman Subramanian

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)

Article Nutrition & Dietetics

Nutritional prevention of colorectal cancer

Mark A. Hull

Summary: Preventability estimate for colorectal cancer (CRC) is approximately 50%, with evidence that dietary factors affect CRC risk, though limited public health impact. Chemoprevention using supplements may provide an effective approach.

PROCEEDINGS OF THE NUTRITION SOCIETY (2021)

Letter Gastroenterology & Hepatology

Using faecal immunochemical test (FIT) undertaken in a national screening programme for large-scale gut microbiota analysis

Andrea C. Masi, Sara Koo, Christopher A. Lamb, Mark A. Hull, Linda Sharp, Andrew Nelson, James S. Hampton, Colin J. Rees, Christopher J. Stewart

Article Gastroenterology & Hepatology

A risk-stratified approach to colorectal cancer prevention and diagnosis

Mark A. Hull, Colin J. Rees, Linda Sharp, Sara Koo

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Omega-3 polyunsaturated fatty acids: moving towards precision use for prevention and treatment of colorectal cancer

Joanna Aldoori, Andrew J. Cockbain, Giles J. Toogood, Mark A. Hull

Summary: Experimental studies have shown that marine omega-3 polyunsaturated fatty acids have anti-inflammatory and anticancer properties. Clinical data suggest that the activity of O3FAs in colorectal cancer depends on host and tumor characteristics, and further investigation is needed on the effect of O3FAs on gut microbiota for optimal prevention and treatment of CRC.
Article Genetics & Heredity

Investigation of the association between high arachidonic acid synthesis and colorectal polyp incidence within a generally healthy UK population: a Mendelian randomisation approach

Rachel Moon, J. Bernadette Moore, Mark A. Hull, Michael A. Zulyniak

Summary: Blood levels of ARA do not associate with colorectal polyp incidence in a general healthy population.

LIFESTYLE GENOMICS (2022)

Article Gastroenterology & Hepatology

Colorectal polyp outcomes after participation in the seAFOod polyp prevention trial: Evidence of rebound elevated colorectal polyp risk after short-term aspirin use

Amy Downing, Hayley Fenton, Claire Nickerson, Paul M. Loadman, Elizabeth A. Williams, Colin J. Rees, Louise C. Brown, Eva J. A. Morris, Mark A. Hull

Summary: This study investigates the risk of colorectal polyps after short-term aspirin use. The results show that individuals who received aspirin demonstrated increased colorectal polyp risk during post-trial surveillance. This has important implications for aspirin cessation driven by age-related bleeding risk.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Oncology

The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E2 synthesis and platelet activation in participants of the seAFOod polyp prevention trial

Ge Sun, Harriett Fuller, Hayley Fenton, Amanda D. Race, Amy Downing, Elizabeth A. Williams, Colin J. Rees, Louise C. Brown, Paul M. Loadman, Mark A. Hull

Summary: Urinary levels of PGE-M and 11-d-TXB2 are reduced by aspirin and EPA, and high levels of 11-d-TXB2 predict increased risk of colorectal polyps.

INTERNATIONAL JOURNAL OF CANCER (2023)

No Data Available